PCMA responds to government funding anti-fraud programs

WASHINGTON The leader of a group representing the nation’s pharmacy benefit managers responded to a House subcommittee's decision to allot $561 million for programs designed to combat fraud, waste and abuse.

Pharmaceutical Care Management Association president and CEO Mark Merritt said the decision shows “it’s more important than ever to enhance America’s overall program integrity capabilities.” The money was provided to the Department of Health and Human Services, the Centers for Medicare and Medicaid Services and the Justice Department.

“The administration has noted that these kinds of efforts can save almost $10 billion,” Merritt said. “The other side of the anti-fraud coin is that policymakers must reject policies that inadvertently weaken the ability of public and private payers to detect and prevent waste, fraud and abuse. It’s far easier to prevent fraud than to engage in ‘pay and chase’ activities after the fact.”

Login or Register to post a comment.